New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists PressReach · Feb 21, 2025
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers PressReach · Feb 21, 2025
Compliancy Group Earns Spot on G2's 2025 Best Healthcare Software Products List PressReach · Feb 20, 2025
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services PressReach · Feb 20, 2025
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 - Conference Call to Follow PressReach · Feb 20, 2025
EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN PressReach · Feb 20, 2025
